Tumors | Chromosomal regions (gene) | OR |
Glioma | 16q23.1-q23.2 | 1.21 for 1-copy deletion 1.94 for 2-copy deletion |
Neuroblastoma | 1q21.1 (NBPF23) | 2.49 for deletion |
Nasopharyngeal carcinoma | 6p21.3 (MICA & HCP5) | 18.92 in males |
Esophageal squamous cell carcinoma | 13q32.1 (ABCC4) | 3.36 for gain |
Gastric cancer | 5q22 (APC-exon9) | 0.48 for gain |
Colorectal cancer | 4q13 (UGT2B17) 12p12.3 (RERGL) | 0.82 for deletion 1.66 for gain |
Pancreatic cancer | 6q13 5q22.2 (YTHDC2), loss | 1.31 for 1-copy - |
Lung cancer | 1q32 (MAPKAPK2) 16q23 (WWOX) | 1.94 for 2- or 3-copies 1.39 for 0- or 1-copy |
Breast cancer | 22q13.1-q13.2 (APOBEC3)
15q26.3 (two CNVs) 3p11.1 (EPHA3) | 1.31 for 1-copy deletion 1.76 for 2-copy deletion 22.3 for deletion 1.96 for deletion |
Testicular tumor (germ cell cancer) | 20q13.1-q13.2 (PTPN1) | 12.31 for deletion |
Prostate cancer | 14q32.33 (IGHG3), gain 2p24.3 22q11.23 (GSTT1) | - 1.31 for deletion 4.89 for >3 copies |
Urinary bladder cancer | 1p13.3 (GSTM1) | 0.56 for two copies |